AHA GUIDELINES Bundle (free trial)

High Blood Pressure - Merck Supported

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1539869

Contents of this Issue

Navigation

Page 17 of 87

18 Evaluation and Diagnosis YES YES 1 Screen for primary aldosteronism and other secondary forms of HTN Positive screening test? • Drug-resistant/induced HTN • Abrupt onset of HTN • Onset of HTN at <30 y • Exacerbation of previously controlled HTN • Disproportionate TOD for degree of HTN • Accelerated/malignant HTN • Onset of diastolic HTN in older adults (age ≥65 y) • Unprovoked or excessive hypokalemia • Insomnia or daytime sleepiness • Concomitant adrenal nodule • History of early-onset stroke • Family history of primary aldosteronism Does the patient have any of the following conditions associated with secondary HTN? 2b Refer to clinician with specific secondary HTN expertise Figure 5. Screening for Features Suggesting Secondary Hypertension Refer to Table 10 for additional tests for secondary hypertension. HTN indicates hypertension; and TOD, target organ damage (eg, cerebrovascular disease, hypertensive retinopathy, left ventricular hypertrophy, left ventricular dysfunction, HF, coronary artery disease, CKD, albuminuria, PAD). Modified with permission from Whelton et al. Copyright © 2018 American College of Cardiology Foundation and American Heart Association, Inc.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - High Blood Pressure - Merck Supported